| Flow cytometry (TLR) | RFLP (TLR) |
---|---|---|
Number of samples analyzed patients/controls | 76:67 | 76:67 |
Age at enrollment | 13.4 (0–26) | 13.4 (0–26) |
[median (range) years] | ||
Age at onset | 6.3 (0–12) | 6.3 (0–12) |
[median (range) years] | ||
Disease duration | 4.7 (1–11) | 4.7 (1–11) |
[median (range) years] | ||
Disease activity | Â | Â |
No or low activity [n] | 63 | 63 |
High activity/flare [n] | 13 | 13 |
ESR (mm/h) | 19 (0–103) | 19 (0–103) |
CRP (mg/l) | 15 (1–372) | 15 (1–372) |
Male/female | 26:50 | 26:50 |
HLA B27 positive | 11 | 11 |
Patients on | Â | Â |
DMARDS | 29 | 29 |
NSAIDS | 12 | 12 |
Steroids | 3 | 3 |